Thetis Pharmaceuticals is Biotechnology in United States that focus on inflammation resolution business. Founded in 2011. They cover business area such as developer, small molecule therapy, inflammatory disease, resolvin, potent agonist, inflammation resolution and tissue repair, an overactive inflammatory response, immune function, patient.
2011
( 13 years old in 2024 )
Inflammation Resolution
-
54 Danbury Road
Suite 285
Ridgefield, CT 06877
United States
Private
developersmall molecule therapyinflammatory diseaseresolvinpotent agonistinflammation resolution and tissue repairan overactive inflammatory responseimmune functionpatient
* We use standard office opening hours in near Thetis Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Thetis Pharmaceuticals is Biotechnology business from United States that founded in 2011 (13 years old in 2024), Thetis Pharmaceuticals business is focusing on Inflammation Resolution.
Thetis Pharmaceuticals headquarter office and corporate office address is located in 54 Danbury Road Suite 285 Ridgefield, CT 06877 United States.
Thetis Pharmaceuticals was founded in United States.
In 2024, Thetis Pharmaceuticals is currently focus on inflammation resolution sector.
Above is snippet of Google Trends for "inflammation resolution" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Thetis Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
